About Cartesian Therapeutics, Inc. 
Cartesian Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 32 Schemes (16.0%)
Foreign Institutions
Held by 32 Foreign Institutions (3.11%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
16 Million
Pharmaceuticals & Biotechnology
USD 265 Million (Micro Cap)
NA
0.00%
61.94
-999,999.00%
-104.85






